Skip to main content

Nonprofit · EIN 73-1627787

SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS

Also known as SABPA SAN DIEGO

Tax-exempt · SAN DIEGO, CA 92192

Financials

$187K$173K2023$263K$227K2024
Revenue Expenses · by fiscal year end
Financials of SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$262,586$227,141$35,445$422,360$0$422,360
December 31, 2023990-EZ$186,695$172,760$13,935$386,913$0$386,913
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$48,380
Membership dues
$29,466
Program service revenue
$205,481
Investment income
$8,725
Other revenue
$0

Expenses

Grants and similar amounts paid
$0
Salaries, compensation and benefits (total)
$0
Professional fundraising fees
$0
Legal fees
$140
Accounting fees
$15,391
Depreciation
$909
Program services (functional)
$218,899
Management and general (functional)
$8,242

Balance sheet and other

Total assets, start of year
$386,915
Total assets, end of year
$422,360
Total liabilities, end of year
$0
Net assets, end of year
$422,360
Land, buildings and equipment
$1,366
Net assets without donor restrictions
$422,360
Gross receipts
$262,586
Employees
0
Volunteers
30
Year formed
2002
State of legal domicile
CA

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
PETER Q HUANGBOARD CHAIR
Trustee or director, Officer
5$0
STEPHANIE SHIBOARD MEMBER
Trustee or director
3$0
HUAINA LIBOARD MEMBER
Trustee or director
3$0
YINGHONG GAOBOARD MEMBER
Trustee or director
3$0
MINGZHU ZHANGBOARD MEMBER
Trustee or director
3$0
WEIJUN SHENBOARD MEMBER
Trustee or director
3$0
JC XUBOARD MEMBER
Trustee or director
3$0
HUA GONGBOARD VICE CHAIRMAN AND PRESIDENT
Trustee or director, Officer
5$0
YI LIUBOARD MEMBER
Trustee or director, Officer
5$0
MING GUOBOARD MEMBER
Trustee or director
3$0
JASON WANGVICE CHAIR, PRESIDENT OF OC/LA CHAPTER
Trustee or director, Officer
5$0
HAOJUN FUVICE CHAIR
Trustee or director, Officer
5$0
HUI WANGBOARD MEMBER
Trustee or director
3$0
PENGYU YANGBOARD MEMBER
Trustee or director
3$0
JOCELYN YUBOARD MEMBER
Trustee or director
3$0
11 more people on this return
NameTitleHours / weekCompensation
DONG HANBOARD MEMBER
Trustee or director
3$0
JIAN LIUBOARD MEMBER
Trustee or director
3$0
ANDREW WANGBOARD MEMBER
Trustee or director
3$0
DAVID WALLACEBOARD MEMBER
Trustee or director
3$0
TRACEY YEOBOARD MEMBER
Trustee or director
3$0
ZHEN ZHUBOARD MEMBER
Trustee or director
3$0
XIA DINGSECTARY OF BOARD
Trustee or director, Officer
5$0
VIVIAN CHANGTREASURE CHAIR, OC/LA CHAP
Officer
5$0
YANG LIUTREASURE CHAIR, SD CHAPTER
Officer
5$0
DONGMEI HUANGPRESIDENT ELECT OF THE SD CHAPTER
Officer
5$0
WEIJUN FANCFO
Officer
3$0
990-EZ for the year ended December 31, 2023: 12 people
NameTitleHours / weekCompensation
STEPHANIE SHIBOARD MEMBER1$0
MINGZHU ZHANGBOARD MEMBER1$0
WEIJUN SHENBOARD MEMBER1$0
JC XUBOARD MEMBER1$0
JIAN LIUBOARD MEMBER1$0
YI LIUBOARD MEMBER5$0
ANDREW WANGBOARD MEMBER1$0
HUAINA LIBOARD MEMBER1$0
YANG LIUBOARD MEMBER1$0
TRACEY YEOBOARD MEMBER1$0
ZHEN ZHUBOARD MEMBER1$0
PENGYU YANGBOARD MEMBER1$0

Address and contacts

Address (IRS master file)
PO BOX 927631, SAN DIEGO, CA 92192-7631
In care of
% JIANGLI YAN
Principal officer (990 for 2024)
YI LIU, PO BOX 927631, SAN DIEGO, CA 921927631
Signed the 990
YI LIU, PRESIDENT
Phone
(858) 531-8164
Return prepared by
LUCY XIA CPA

California records

California keeps its own records of charities and corporations. Search them by EIN 73-1627787 or by the name SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS.

Attorney General, Registry of Charities and Fundraisers
Registration status and filed reports (CT-TR-1, RRF-1)

Mission

SABPA'S PRIMARY MISSION AND MOST SIGNIFICANT ACTIVITIES ARE TO PROMOTE SCIENCE AND INNOVATION. (1). TO PROVIDE FORUMS FOR FACILITATING INTERACTION AND COMMUNCATIONS AMONG BIOTECHINAL PROESSIONALSIONALS IN GLBOAL SCIENCE AND TECHNOLOGY ARENA;(2). TO PROMOTE INTERACTION AND COLLABORATION IN SCIENCE AND TECHNOLOGY ACROSS THE PACIFIC REGIONS; AND(3). TO STIMULATE AND NURTURE THE INNOVATIVE IDEAS, CUTTING-EDGE TECHNOLOGIES, ENTREPRENEURSHIP AND BRINGING PUBLIC AWARENESS OF THE BENEFITS OF BIOMEDICAL RESEARCH.

990 for the year ended December 31, 2024

Program accomplishments

  • The 20th San Diego SABPA BioPharma Conference (October 5, 2024)Address: Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CAFor the past 20 years, San Diego BioPharma Conference, the flagship event of SABPA, has witnessed the boom of the pharmaceuticals and biotechnology industry in one of the nation's premier innovation centers. From potential Nobel laureates and technologically disruptive inventors to entrepreneurs and multi-billion-dollar dealmakers, this annual conference has been featuring some of the most respectful figures in the fields. This year, the long-awaited in-person conference is back.Program highlights are as follows:1. Fireside Chats on Taking a Research Organization towards Commercialization2. Breakthrough Prize Winner achievements in Serial Innovation in Drug Development3. The journey From Academia to Industry in Neuroscience IPOs4. Discovering the transformative impact of Moores Cancer Center's New Director, a world-renowned Pancreatic SurgeonDelving into cutting-edge innovations like Next-Gen Chemo proteomics Platforms
    Expenses $127,897 · revenue $119,998
  • The 8th Annual Frontiers in Therapeutics and Diagnostics (FTD) Forum (March 23, 2024)Address: Hilton San Diego/Del Mar, 15575 Jimmy Durante Blvd, Del Mar, CASABPA FTD annually brings together the latest in groundbreaking research, cutting-edge drugs, and industry trends within the biopharma sector. The event's broad spectrum of topics provides a platform for local biotech companies to engage in vibrant discussions and valuable networking opportunities. The forthcoming 8th FTD Conference was set to shine a spotlight on three revolutionary domains in the field of metabolism disease and oncology: Glucagon-like peptide-1 (GLP-1), Antibody-Drug Conjugates (ADC), and Minimal Residual Disease (MRD), each representing the forefront of innovations in therapeutics and diagnostics. Program highlights are as follows:1. GLP-1 receptor agonists, from diabetes to obesity and beyond2. The rise of ADC - a biological missile, for targeted cancer therapy3. Reinventing drug discovery with AI-powered automation4. Frontiers in MRD detection to increase chance of cancer cure
    Expenses $72,008 · revenue $66,077
  • SABPA OC/LA 16th Annual Biomedical Forum (April 20, 2024)Address: The Beckman Center, 100 Academy, Irvine, CA, 92617SABPA OC/LA annually brings together the latest innovations in biomedical industries, cutting-edge developments of pharmaceuticals and medical devices, entrepreneurship, and career development. The event's broad spectrum of topics provides a platform for local biotech and medical device companies to engage in vibrant discussions and valuable networking opportunities.
    Expenses $18,994 · revenue $19,406

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990-EZ on file

IRS record

EIN
73-1627787
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2002
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$422,360
Income (IRS master file)
$262,586

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$262,586$227,141$422,360XML
990-EZDecember 2023$186,695$172,760$386,913XML
990-EZDecember 2022–––IRS
990-EZDecember 2021–––IRS
990-EZDecember 2020–––IRS
990-EZDecember 2019–––IRS
990December 2018–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 73-1627787).

Questions about SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS

What is the EIN of SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS?
The employer identification number (EIN) of SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS is 73-1627787.
Is SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2002.
Are donations to SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS?
The 990 for the year ended December 31, 2024 names YI LIU.
Who are the officers and directors of SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS?
The 990 for the year ended December 31, 2024 lists 26 people; 0 received compensation from the organization.
How much revenue does SOCAL ASSOCIATION FOR BIOMEDICAL AND PHARMACEUTICAL ADVANCEMENTS have?
On its 990 for the year ended December 31, 2024 it reported revenue of $262,586, expenses of $227,141 and total assets of $422,360 at year end.

Other nonprofits in SAN DIEGO

All nonprofits in SAN DIEGO · California · Science and technology